Results
|
2601.
|
|
|
2602.
|
|
|
2603.
|
|
|
2604.
|
|
|
2605.
|
|
|
2606.
|
|
|
2607.
|
|
|
2608.
|
|
|
2609.
|
|
|
2610.
|
|
|
2611.
|
|
|
2612.
|
TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimens. [electronic resource] by
- Hikichi, Yuichi
- Honda, Kohei
- Hikami, Kouki
- Miyashita, Hitoshi
- Kaieda, Isao
- Murai, Saomi
- Uchiyama, Noriko
- Hasegawa, Maki
- Kawamoto, Tomohiro
- Sato, Takashi
- Ichikawa, Takashi
- Cao, Sheldon
- Nie, Zhe
- Zhang, Lilly
- Yang, Johnny
- Kuida, Keisuke
- Kupperman, Erik
Producer: 20120709
In:
Molecular cancer therapeutics vol. 11
Availability: No items available.
|
|
2613.
|
|